Categories for Policy
Office of Wastewater Management (4203M)Office of WaterU.S. Environmental Protection Agency1200 Pennsylvania Ave., NWWashington, DC 20460via www.regulations.gov Multi-Association Comments Opposing Refined... View Article
OSHA has issued two revised guidance memos on recordkeeping and enforcement in response to the COVID-19 pandemic. On May 26, 2020, the previous memos from April on these topics will be rescinded, and the new memos will go into and remain in effect until further notice.
April 20, 2020 Re: FEMA Initiative to Provide Cloth Masks to Critical Infrastructure The Federal Emergency Management Agency (FEMA) has initiated... View Article
OSHA has issued a new memorandum on Discretion in Enforcement when Considering an Employer’s Good Faith Efforts During the COVID-19 Pandemic, which applies broadly to all industry sectors and will take effect immediately and remain in effect until further notice.
Last Updated April 16, 2020 Summary of Legislative and Regulatory Issues Related to COVID-19 This chart is a quick reference... View Article
The following frequently asked questions address fee requirements for manufacturers and importers identified in preliminary lists as fee-obligated entities for the next 20 high priority chemical substances undergoing Toxic Substances Control Act (TSCA) risk evaluations by U.S. Environmental Protection Agency (EPA).
The U.S. Occupational Safety and Health Administration (OSHA) has issued new Enforcement Guidance for Respiratory Protection and the N95 Shortage Due to the Coronavirus Disease 2019 (COVID19) Pandemic. This memorandum is applicable to all industries and provides interim guidance to Compliance Safety and Health Officers (CSHOs) for enforcing the Respiratory Protection standard, 29 CFR § 1910.134, and certain other health standards, with regard to supply shortages of disposable N95 filtering facepiece respirators.
The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.
S. 3548 Coronavirus Aid, Relief, and Economic Security Act Updated: March 30, 2020 | Originally Posted: March 23, 2020 President... View Article
The following guidance addresses OSHA health and safety regulatory requirements related to the current COVID-19 pandemic.